Fagron, Inc. is recalling 182 containers of Nandrolone Decanoate USP, a medication used for prescription compounding, because the drug is subpotent (weaker than it should be). The recall includes containers in 100 g, 500 g, and 1 kg sizes distributed under both the Fagron and Humco brand names. No incidents or injuries have been reported to date in connection with this recall.
A subpotent medication may not provide the full therapeutic effect intended by a healthcare provider, which could lead to inadequate treatment for the patient's condition.
You have 2 options:
Fagron, Inc. brand.
Fagron, Inc. brand.
Fagron, Inc. brand.
Distributed by Humco.
Distributed by Humco.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.